These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN. J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296 [Abstract] [Full Text] [Related]
3. Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study. MacMahon SW, Macdonald GJ. Am J Med; 1986 Feb 14; 80(2A):40-7. PubMed ID: 3946460 [Abstract] [Full Text] [Related]
4. Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring. Hubert HB, Eaker ED, Garrison RJ, Castelli WP. Am J Epidemiol; 1987 May 14; 125(5):812-31. PubMed ID: 3565356 [Abstract] [Full Text] [Related]
5. Cholesterol, lipoproteins, and coronary heart disease in women. Bush TL, Fried LP, Barrett-Connor E. Clin Chem; 1988 May 14; 34(8B):B60-70. PubMed ID: 3042201 [Abstract] [Full Text] [Related]
7. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. Genest J, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PW, Salem DN, Schaefer EJ. J Am Coll Cardiol; 1992 Mar 15; 19(4):792-802. PubMed ID: 1531990 [Abstract] [Full Text] [Related]
13. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Kannel WB, Castelli WP, Gordon T. Ann Intern Med; 1979 Jan 10; 90(1):85-91. PubMed ID: 217290 [Abstract] [Full Text] [Related]
14. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Am J Cardiol; 1980 Oct 10; 46(4):649-54. PubMed ID: 7416024 [Abstract] [Full Text] [Related]
15. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease. Pennell P, Leclercq B, Delahunty MI, Walters BA. Clin Nephrol; 2006 Nov 10; 66(5):336-47. PubMed ID: 17140163 [Abstract] [Full Text] [Related]
16. Factors associated with lipoprotein cholesterol levels. The Framingham study. Wilson PW, Garrison RJ, Abbott RD, Castelli WP. Arteriosclerosis; 1983 Nov 10; 3(3):273-81. PubMed ID: 6573878 [Abstract] [Full Text] [Related]
17. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. MacMahon SW, Macdonald GJ, Blacket RB. Arteriosclerosis; 1985 Nov 10; 5(4):391-6. PubMed ID: 4015511 [Abstract] [Full Text] [Related]
18. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N. Indian Heart J; 2003 Nov 10; 55(3):234-40. PubMed ID: 14560932 [Abstract] [Full Text] [Related]